MarkNtel Advisors recently published a detailed industry analysis of the UAE Left Ventricular Assist Devices (LVADs) Market. The report covers growth trends, geographical marketing strategies, challenges, opportunities, and drivers influencing the market.
UAE Left Ventricular Assist Devices (LVADs) Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2030
The UAE Left Ventricular Assist Devices (LVADs) Market size was valued at around USD 391.29 million in 2024 and is projected to reach USD 511.22 million by 2030. Along with this, the market is estimated to grow at a CAGR of around 4.45% during the forecast period, i.e., 2025-30.
What are the major Driver the UAE Left Ventricular Assist Devices (LVADs) industry?
Increasing Prevalence of Heart Failure in the UAE – Increasing heart failure rate is the primary factor driving the growth of the left ventricular assist device market in the United Arab Emirates. Coronary heart disease leads to maximum deaths in UAE with 40% of all fatalities attributed to cardiovascular diseases in this country as per the Ministry of Health and Prevention. Since Heart failure is common in the aged population, hence modern treatments like LVADs are required. By the end of 2050, there is a probability of 2 million people in the United Arab Emirates to be 60 years of age or older. It is expected that this demographic shift will similarly increase demand for LVADs as heart failure will become more frequent in older adults. Similarly contributing to the rising prevalence of coronary heart failure are lifestyle factors including obesity rates that surpass 28% and the roughly 50% of individuals being overweight. The need for LVADs is similarly increased by a sedentary lifestyle that increases heart-related troubles.
Our Latest Reports Now Include In-Depth Supply Chain Ecosystem Analysis, Enabling Businesses to Navigate Tariff Challenges with Greater Agility Get Sample Report: https://www.marknteladvisors.com/query/request-sample/uae-lvads-market.html
What segments define the UAE Left Ventricular Assist Devices (LVADs) market from 2025 to 2030? How do these segments contribute to market dynamics and growth?
· By Type of Flow
o Pulsatile Flow – Market Size & Forecast 2020-2030, USD Million
o Non-Pulsatile Flow – Market Size & Forecast 2020-2030, USD Million
According to report, The Non-Pulsatile flow segment currently leads the UAE LVADs market, representing more than 70% of the market share.
· By Design
o Implantable Ventricular Assist Devices – Market Size & Forecast 2020-2030, USD Million
o Transcutaneous Ventricular Assist Devices – Market Size & Forecast 2020-2030, USD Million
· By Application
o Bridge to Transplantation – Market Size & Forecast 2020-2030, USD Million
o Destination Therapy – Market Size & Forecast 2020-2030, USD Million
o Bridge to Recovery – Market Size & Forecast 2020-2030, USD Million
o Bridge to Candidacy – Market Size & Forecast 2020-2030, USD Million
According to report, The Bridge to Transplantation segment is the leading application in the UAE LVADs market holding up to 75% of the market share.
Explore the Complete UAE Left Ventricular Assist Devices (LVADs) Market Analysis Report – https://www.marknteladvisors.com/research-library/uae-lvads-market.html
Geographical Analysis: UAE Left Ventricular Assist Devices (LVADs) Market
o Dubai
o Abu Dhabi
o Sharjah
o Northern Emirates
UAE Left Ventricular Assist Devices (LVADs) Market Share & Competitive Landscape:
The UAE Left Ventricular Assist Devices (LVADs) Market is characterized by intense competition, with several key players driving growth through innovation, market expansion, and strategic investments. The competitive landscape provides valuable insights into the industry’s leading companies, highlighting their strengths, financial performance, and market influence.
Leading Companies in the UAE Left Ventricular Assist Devices (LVADs) Market are:
- Abbott Laboratories
- Cadrenal Therapeutics
- Fresenius Medical Care AG & Co. KGaA
- Abiomed Inc.
- Teleflex Incorporated
- SynCardia Systems
- CardiacAssist, Inc.
- Jarvik 2000
- Reliant Heart
- Edwards Lifesciences
- GE Healthcare
UAE Left Ventricular Assist Devices (LVADs) Industry Recent Development:
- August 2024: Abbott and Cadrenal Therapeutics are exploring a collaboration on a pivotal study to assess tecarfarin’s safety and efficacy in preventing blood clots in patients with newly implanted LVADs, aiming to improve anticoagulation treatment.
Questions Addressed in this Study
1.What factors are driving the UAE Left Ventricular Assist Devices (LVADs) Market growth?
2.How is the UAE Left Ventricular Assist Devices (LVADs) Market expected to grow over the next five years?
3.What are the key insights into the current trends in the UAE Left Ventricular Assist Devices (LVADs) Market?
4.What is the current size of the UAE Left Ventricular Assist Devices (LVADs) Market, and how is it projected to change in the future?
6.What is the future outlook for the UAE Left Ventricular Assist Devices (LVADs) Market in terms of technological advancements and market expansion?
For a Customized Analysis Report, Just Drop Your Inquiry Here – https://www.marknteladvisors.com/query/request-customization/uae-lvads-market.html
Why MarkNtel Advisors?
MarkNtel Advisors is a leading research, consulting, & data analytics firm that provides an extensive range of strategic reports on diverse industry verticals. We deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, & individuals, among others.
Our specialization in niche industries & emerging geographies allows our clients to formulate their strategies in a much more informed way and entail parameters like Go-to-Market (GTM), product development, feasibility analysis, project scoping, market segmentation, competitive benchmarking, market sizing & forecasting, & trend analysis, among others, for 15 diverse industrial verticals.
More Research Studies Report:
–Biocomposites Market size was valued at around USD 36.9 billion in 2024 and is projected to reach USD 89 billion by 2030 with a CAGR of around 16%.
–Green Solvents Market size was valued at around USD 1.34 billion in 2024 & is projected to reach USD 1.87 billion by 2030 with a CAGR of around 5.7%.
For Media Inquiries, Please Contact:
Email: sales@marknteladvisors.com
Sales Office: 564 Prospect St, B9, New Haven, Connecticut, USA-06511
Corporate Office: Office No.109, H-159, Sector 63, Noida, Uttar Pradesh-201301, India
